Seeds of Cornus officinalis and Diabetic Cataracts

Handbook of Nutrition, Diet and the Eye

Volumn , Issue , 2014, Pages 451-458

  Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Advanced glycation end product; Aldose reductase; Bovine serum albumin; Collagen cross linking; Cornus officinalis; Cornus officinalis seed; Diabetic cataract; Galloyl glucose; Xylose induced cataractogenesis

Indexed keywords

EID: 84935019982     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-401717-7.00045-9     Document Type: Chapter

References (32)

1. Kyselova Z., Stefek M., Bauer V. Pharmacological prevention of diabetic cataract. J Diabetes Complications 2004, 18:129-140.
2. Yokozawa T., Yamabe N., Kim H.Y., Kang K.S., Hur J.M., Park C.H., Tanaka T. Protective effects of morroniside isolated from corni fructus against renal damage in streptozotocine-induced diabetic rats. Biol Pharm Bull 2008, 31:1422-1428.
3. Edelstein D., Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidin. Diabetes 1992, 41:26-29.
4. Soulis T., Cooper M.E., Bucala R., Jerums G. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 1996, 50:627-634.
5. Vasan S., Foiles P., Founds H. Therapeutic potential of breaker of advanced glycation end product-protein crosslinks. Arch Biochem Biophys 2003, 419:89-96.
6. Schemmel K.E., Padiyara R.S., D'Souza J.J. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications 2010, 24:354-360.
7. Park C.H., Noh J.S., Tanaka T., Uebaba K., Cho E.J., Yokozawa T. The effects of corni fructus extract and its fractions against α-glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats. Am J Chin Med 2011, 39:367-380.
8. He L-H. Comparative study for α-glucosidase inhibitory effects of total glycosides in the crude products and the wine-processed products from. Cornus officinalis. Yakugaku Zasshi 2011, 131:1801-1805.
9. Qian D.S., Zhu Y.F., Zhu Q. Effect of alcohol extract of Cornus officinalis Sieb. et Zucc on GLUT4 expression in skeletal muscle in type 2 (non-insulin-dependent) diabetic mellitus rats. Zhongguo Zhong Yao Za Zhi 2001, 26:859-862.
10. Kim O.K. Antidiabetic and antioxidative effects of corni fructus in streptozotocin-induced diabetic rats. J Korea Oil Chem Soc 2005, 22:157-167.
11. Chen C.C., Hsu C.Y., Chen C.Y., Liu H.K. Fructus corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. J Ethnopharmacol 2008, 117:483-490.
12. Yamabe N.Y., Kang K.S., Goto E., Tanaka T., Yokozawa T. Beneficial effect of corni fructus, a constituent of hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol Pharm Bull 2007, 30:520-526.
13. Okuda T., Hatano T., Ogawa N., Kira R., Matsuda M., Cornusiin A. a dimeric ellagitannin forming four tautomers, and accompanying new tannins in Cornus officinalis. Chem Pharm Bull 1984, 32:4662-4665.
14. Hatano T., Ogawa N., Kira R., Yasuhara T., Okuda T. Tannins of cornaceous plants. I. Cornusiins A, B and C, dimeric monomeric and trimeric hydrolyzable tannins from Cornus officinalis, and orientation of valoneoyl group in related tannins. Chem Pharm Bull 1989, 37:2083-2090.
15. Hatano T., Yasuhara T., Abe R., Okuda T. A galloylated monoterpene glucoside and a dimeric hydrolysable tannin from Cornus officinalis. Phytochemistry 1990, 29:2975-2978.
16. Yamabe N., Kang K.S., Park C.H., Tanaka T., Yokozawa T. 7-O-Galloyl-D-sedohepulose is a novel therapeutic agent against oxidative stress and advanced glycation end product in the diabetic kidney. Biol Pharm Bull 2009, 32:657-664.
17. Endo T., Taguchi H. Study on the constituents of Cornus officinalis Sieb et Zucc. Yakugaku Zasshi 1973, 93:30-32.
18. Lin M.H., Liu H.K., Huang C.C., Wu T.H., Hsu F.L. Evaluation of the potential hypoglycemic and beta-cell protective constituents isolated from corni fructus to tackle insulin-dependent diabetes mellitus. Agric Food Chem 2011, 59:7743-7751.
19. Kim D.K., Kwak J.H. A furan derivative from Cornus officinalis. Arch Pharm Res 1998, 21:787-789.
20. Kim D.K., Kwak J.H., Ryu J.H., Kwon H.C., Song K.W., Kang S.S., et al. A component from Cornus officinalis enhances hydrogen peroxide generation from macrophages. Korean J Pharmacogn 1996, 27:101-104.
21. Miyazawa M., Kameoka H. Volatile flavor components of corni fructus (Cornus officinalis Sieb. et Zucc.). Agric Biol Chem 1989, 53:3337-3340.
22. Miyazawa M., Anzai J., Fujioka J., Isikawa Y. Insecticidal compounds against drosophila melanogaster from Cornus officinalis Sieb. et Zucc. Nat Prod Res 2003, 17:337-339.
23. Kim Y.D., Kim H.K., Kim K.J. Analysis of nutritional components of Cornus officinalis. J Korean Soc Food Sci Nutr 2003, 32:785-789.
24. Jiang W.L., Zhang S.P., Hou J., Zhu H.B. Effect of loganin on experimental diabetic nephropathy. Phytomedicine 2012, 19:217-222.
25. Yokozawa T., Kang K.S., Park C.H., Nog J.S., Yamabe N., Shibahara N., Tanaka T. Bioactive constituents of Cornus fructus: the therapeutic use of morroniside, loganin, and 7-O-galloyl-D-sedoheptulose as renoprotective agent in type 2 diabetes. Drug Discov Ther 2010, 4:223-234.
26. Xu H., Shen J., Liu H., Shi Y., Li L., Wei M. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress. Can J Physiol Pharmacol 2006, 84:1267-1273.
27. Wang W., Xu J., Li L., Wang P., Ji X., Ai H., et al. Neuroprotective effect of morronisied on focal cerebral ischemia in rats. Brain Res Bull 2010, 83:196-201.
28. Qi M.-Y., Liu H.-R., Dai D.-Z., Li N., Dai Y. Total triterpene acids, active ingredients from fructus corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocine-rats. J Pharm Pharmacol 2008, 60:1687-1694.
29. Lee G.Y., Jang D.S., Lee Y.M., Kim Y.S., Kim J.S. Constituents of the seeds of Cornus officinalis with inhibitory activity on the formation of advanced glycation end products (AGEs). J Korean Soc Appl Biol Chem 2008, 51:316-320.
30. Lee J., Jang D.S., Kim N.H., Lee Y.M., Kim J.H., Kim J.S. Galloyl glucoses from the seeds of Cornus officinalis with inhibitory activity against protein glycation, aldose reductase, and cataractogenesis ex vivo. Biol Pharm Bull 2011, 34:443-446.
31. Kim C.S., Jang D.S., Kim J.H., Lee G.Y., Lee Y.M., Kim Y.S., Kim J.S. Inhibitory effects of the seeds of Cornus officinalis on AGEs formation and AGEs-induced protein cross-linking. Korean J Pharmacogn 2008, 39:249-254.
32. Park Y.K., Whang W.K., Kim H.I. The antidiabetic effects of extract from Cornus officinalis seed. Chung-Ang J Pharm Sci 1995, 9:5-11.